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Abstract
Word count : 237
 
Platelet s are special ized anucleate cel ls t hat  play a maj or role in hemostasis fol lowing vessel inj ury.  More recent ly,  plat elet s have
also been impl icat ed in innat e immunit y and inf lammat ion by direct ly int eract ing wit h immune cel ls and releasing proinf lammat ory
signals.  It  is l ikely t herefore t hat  in cert ain pat hologies,  such as chronic parasit ic infect ions and myeloid mal ignancies,  plat elet s can
act  as mediat ors for hemost at ic and proinf lammat ory responses.  Fort unat ely,  murine plat elet  funct ion ex vivo is highly analogous
t o human,  providing a robust  model for funct ional comparison.  However,  t radit ional  met hods of  st udying plat elet  phenot ype,
funct ion and act ivat ion st at us of t en rely on using large numbers of  whole isolat ed plat elet  populat ions,  which severely l imit s t he
number and t ype of  assays t hat  can be performed wit h mouse blood.  Here,  using cut t ing edge 3D quant i t at ive phase imaging,
holot omography,  t hat  uses opt ical  dif f ract ion t omography (ODT),  we were able t o ident ify and quant ify dif ferences in single
unlabeled,  l ive plat elet s wit h minimal experimental int erference.  We analyzed plat elet s direct ly isolat ed f rom whole blood of  mice
wit h eit her a JAK2V617F-posit ive myeloprol i ferat ive neoplasm or Leishmania donovani infect ion.  Image analysis of  t he plat elet s
indicates previously uncharacterized dif ferences in plat elet  morphology,  including alt ered cel l  volume and sphericit y,  as wel l  as
changes in biophysical  paramet ers such as ref ract ive index and dry mass.  Toget her,  t hese dat a indicat e t hat ,  by using
holot omography,  we were able t o ident i fy clear disparit ies in act ivat ion st at us and pot ent ial  funct ional  abi l i t y in disease st at es
compared t o cont rol at  t he level of  single platelet s.
  
 
Contribut ion to the field
Plat elet s are special ised anucleat e cel ls t hat  have been shown t o play a crucial  role in innat e immunit y and inf lammat ion by
int eract ing wit h immune cel ls and releasing proinf lammat ory signal .  In t his st udy we have used 3D opt ical  di f f ract ion t omography
(ODT) t o st udy t he dif ferences in l ive,  unf ixed and unlabel led platelet s f rom murine models of  myeloid malignancy and parasit ic
infect ions where plat elet s can act  as mediat ors for hemost at ic and proinf lammat ory responses.  Convent ional  f luorescence imaging
requires post  isolat ion cel l  processing,  f ixat ion and label l ing,  while platelet -based assays commonly used t o st udy platelet  funct ions
require large amount s of  t he sample.  This t echnique circumvent s t hese t wo l imit at ions in plat elet  biology providing a robust  t ool
for quant it at ive analysis of  single cel ls f rom smal l  sample volumes and requiring no post  isolat ion processing.  Using ODT,  we were
able t o ident i fy,  in t wo pat hological ly dif ferent  disease,  clear disparit ies in t he morphology and ref ract ive index of  diseased or
infect ed plat elet s compared t o i t s WT cont rol .  Thus,  t his met hod provides a complement ary t ool  t hat  can provide addit ive
informat ion on t he cel ls morphology,  cytosol ic f ract ion or l ive cel l  dynamics along wit h convent ional platelet  funct ional assays.
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Abstract  
Platelets are specialized anucleate cells that play a major role in hemostasis following vessel injury. 
More recently, platelets have also been implicated in innate immunity and inflammation by directly 
interacting with immune cells and releasing proinflammatory signals. It is likely therefore that in 
certain pathologies, such as chronic parasitic infections and myeloid malignancies, platelets can act 
as mediators for hemostatic and proinflammatory responses. Fortunately, murine platelet function 
ex vivo is highly analogous to human, providing a robust model for functional comparison. 
However, traditional methods of studying platelet phenotype, function and activation status often 
rely on using large numbers of whole isolated platelet populations, which severely limits the 
number and type of assays that can be performed with mouse blood. Here, using cutting edge 3D 
quantitative phase imaging, holotomography, that uses optical diffraction tomography (ODT), we 
were able to identify and quantify differences in single unlabeled, live platelets with minimal 
experimental interference. We analyzed platelets directly isolated from whole blood of mice with 
either a JAK2V617F-positive myeloproliferative neoplasm or Leishmania donovani infection. 
Image analysis of the platelets indicates previously uncharacterized differences in platelet 
morphology, including altered cell volume and sphericity, as well as changes in biophysical 
parameters such as refractive index and dry mass. Together, these data indicate that, by using 
holotomography, we were able to identify clear disparities in activation status and potential 
functional ability in disease states compared to control at the level of single platelets.   
 
Introduction: 
Maintaining blood flow in basal states and preventing excessive blood loss following injury relies 
on an orchestrated response from different cell types and non-cellular components, such as clotting 
factors. Platelets are key cells in this process, becoming rapidly activated following injury and form 
a platelet plug to reduce blood loss, as well as initiating secondary hemostasis to promote the 
formation of a stable fibrin-rich thrombus (1) Maintaining a physiological number of functional 
platelets is essential for hemostasis. However, a wide variety of pathological conditions lead to 
rapid and sustained changes in platelet counts and functionality. Thrombocytopenia (sustained 
reduction in platelets of <100x103/PL whole blood in humans) is common in autoimmune conditions 
as well as  acute and chronic infections by bacterial, parasitic and viral pathogens including Salmonella, 
Staphylococcus aureus, Plasmodium, Leishmania and dengue virus (2±7).  
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Conversely, thrombocytosis (sustained excess platelet count >450x103/PL whole blood in humans) is 
common in myeloproliferative neoplasms (MPNs), such as essential thrombocythemia (ET). 
Furthermore, platelet production by megakaryocytes can be significantly altered by bone marrow failure 
syndromes, whereas inflammatory conditions often impact platelet functionality.  In addition to being 
essential for hemostasis, there is now compelling evidence suggesting key roles for platelets in 
other processes including wound healing, angiogenesis, inflammation and innate immunity (1, 8).  
Platelets express a range of receptors that allow them to interact with and respond to pathogens and 
assist in regulating an immune response (8±10) . There is complex interplay between platelets and 
bacteria during infections, where the interaction of platelets with immune cells, such as neutrophils 
generate neutrophil traps/net or release immunomodulatory factors for trapping and clearance of 
bacteria.  Platelets can also bind directly to the bacteria to form clots during inflammatory 
endocarditis.  Platelets assist the formation of the traps, and concurrently the nets contribute to 
platelet activation, linking inflammation to thrombosis (10, 11). 
As platelet production and function is comparable between mice and humans, murine models 
provide an excellent platform to study the effects of diverse pathologies on platelet form and 
function. However, traditional methods used for studying platelet phenotype, function and 
activation status often rely on using large numbers of whole isolated platelet populations. The 
limited volume of the blood obtained for isolation of platelets severely restricts the number and 
type of assays that can be performed with mouse blood. Super-resolution imaging techniques have 
recently enabled the study of structural changes in the protein distribution or cytoskeleton changes 
of platelets in disease models (12±14), However, it is important to note that with improvements in 
resolution, the post-isolation processing which entails fixation, permeabilization and labelling, can 
often lead to artefacts if not carefully controlled (14±17).  
Here, using cutting edge 3D quantitative phase imaging, holotomography, which uses optical 
diffraction tomography (ODT), we were able to identify and quantify differences in single 
unlabeled platelets from very small sample volumes. The technique measures 3D differences in the 
refractive index (RI) tomograms that are generated due to alterations in the diffraction patterns 
obtained from the cells. This allows the measurement of cellular changes under live conditions, 
without experimental interferences such as labelling or fixation. With this label-free imaging of the 
samples we can obtain quantitative information such as cellular dry mass (cytoplasmic 
concentration) and information on the cell size or structure (18, 19).   
Using this technique, we analyzed platelets directly isolated from the whole blood of two different 
pathological mouse models. In the first model,  Jak/2E/B6 Stella Cre mice express a mutated 
version of human JAK2 (JAK2V617F) under the control of the endogenous Jak2 promoter (20). 
These mice develop symptoms similar to a JAK2V617F-positive myeloproliferative neoplasm 
(MPN), including increased platelets and erythrocytes, megakaryocyte hyperplasia and markers of 
chronic systemic inflammation. However, the role of JAK2V617F in platelet function remains 
unclear. In vitro analysis of platelets isolated from MPN patients suggests there may be defects in 
signal transduction and integrin activity (21, 22). While in JAK2V617F-positive mouse models, 
studies have suggested changes in platelet aggregation in vitro (23)  and others identify aberrant 
hemostasis in vivo, but no clear platelet phenotype (24, 25).    Furthermore, as chronic inflammation 
is now considered a key characteristic of MPNs, the proinflammatory environment may lead to 
functional changes in platelet activity, leading to the increased incidence of bleeding abnormalities 
in these patients, as reviewed in (26, 27).   
We also analyzed platelets taken from a mouse model of visceral leishmaniasis (VL). In humans, 
VL causes thrombocytopenia and anemia, a phenotype also mirrored in experimental murine 
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models of L. donovani, which is thought to be caused by defective medullary erythropoiesis and 
thrombocytopenia (2, 28, 29). The cause of severe thrombocytopenia in the mouse models of VL 
is unclear, but is likely to be multifactorial, with the parasite infection leading to significant changes 
in the bone marrow microenvironment and increased macrophage activity that would likely lead to 
excessive platelet clearance.   
In this study, using holotomography, we were able to identify distinct platelet phenotypes in both 
disease mouse models that may not have been identifiable using current standard assays.  
 
Materials and Methods: 
 
Ethics statement 
All animal care and experimental procedures were performed under UK Home Office License (Ref 
# PPL 7008596 and P49487014) and with approval from the Animal Welfare and Ethical Review 
Board of the Department of Biology, University of York.  
Mice 
C57BL/6 (WT) and Jak/2E/B6 Stella Cre (20, 30) (herein referred to as VF) mice were bred at the 
University of York. For platelet experiments, heterozygous VF mice where used, which exhibit a   
JAK2V617F+ ET-like phenotype with modest platelet increases, splenomegaly and transformation 
to myelofibrosis.  
 For L. donovani infection experiments, C57BL/6 female mice at six-eight weeks of age used for 
the study. Mice were infected with 3 x 107 amastigotes of the Ethiopian strain of L. donovani (LV9) 
via lateral tail vein, as described (27). All mice were maintained in individually ventilated cages 
(at ACDP CL3, where necessary for infection control). All experimental mice were killed four 
weeks post infection. 
Platelet Isolation 
The WT and VF mice were euthanized with pentobarbital, followed by collection of whole blood 
into acid citrate dextrose (ACD) via cardiac punctures. The collected blood was topped up with 
equal volume of wash buffer (150 mM NaCl, 20 mM HEPES, at RT, pH 6.5) and centrifuged at 60 
g for 7 minutes at room temperature without breaks. The platelet rich plasma (PRP) was collected 
and centrifuged at 240 g for 10 minutes at room temperature to separate platelets and plasma. The 
platelet pellet was resuspended in wash buffer containing 1U/ml of apyrase (Sigma Aldrich, UK) 
and 1µM of prostaglandin E1 (Sigma Aldrich, UK) (31).   
For L. donovani infected mice, whole blood was collected via cardiac puncture after anesthetizing 
the mice with isoflurane inhalation in a secure chamber (Apollo TEC3 Isoflurane Vaporise, Sound 
Veterinary Equipment, Victoria, Australia). Blood was collected in 5ml polystyrene tubes 
(FalconTM) coated with ACD and isolated as above into wash buffer without apyrase and 
prostaglandin E1. 
20 µl of the isolated platelets were then added to a TomoDish (Tomocube Inc.) fluidic chamber 
assembly, where the sample is sandwiched between two #1.5H coverslips.  
Platelet fixation and granule labelling 
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For monitoring the effect of fixation on platelets, 10 µl isolated platelets in wash buffer were added 
to the Tomodish with a coverslip and imaged, followed by addition of 10 µl 8% PFA to  the flow 
chamber in the Tomodish allowing it to diffuse in, making a 4% PFA final concentration within 
the chamber. This was allowed to incubate and imaged every 10 minutes for a total of 30 minutes 
at room temperature (RT).  
For labelling the granules, the isolated platelets were incubated, for 30 minutes at 37(?C, 5% CO2, 
with 50 µM Mepacrine (Q3251-25G, Sigma-Aldrich, UK) to label dense granules or 10 µg/ml of 
BQ-BSA Green (D12050, Invitrogen, Fisher Scientific) to label the alpha granules. After 
incubation, the platelets were washed and plated onto the Tomodish with 4% PFA for 10 minutes 
at RT. The fixative was removed, and the platelets were then imaged in wash buffer.  
Microscopy 
3D Quantitative phase images of platelets were generated using a commercial holotomographic 
microscope (HT-2H, Tomocube Inc.) that employs optical diffraction tomography (ODT) using 
two UPLSAP 60X (NA 1.2) Water dipping lenses (Olympus, Tokyo, Japan). Full details of the 
optical configuration have been previously described here (32, 33). Samples in wash buffer were 
mounted on specialized TomoDishes with No1.5 H coverslips at RT.   
 Statistics 
The data were plotted using GraphPad Prism 8 and data analyzed using unpaired or paired two-
tailed t-tests as indicated in figure legends.  
 
Results: 
3D Holotomography image acquisition and data analysis 
Briefly, the HT-2H microscope is based on a Mach±Zehnder interferometer equipped with a digital 
micromirror device (DMD) (Figure$ 8VLQJ D FRKHUHQW PRQRFKURPDWLF ODVHU Ȝ   QP
divided into a sample and reference beam, 2D holographic QPI images were generated at multiple 
illumination angles (Figure 2B) where the incidence light is accurately controlled by the DMD 
(34). The light beam diffracted by the sample was collected using a high numerical aperture 
1$(? (? REMHFWLYH OHQV 83/6$3 ;: 2O\PSXV 7RN\R -DSDQ ZLWK WKH VXEVHTXHQW
holograms recorded on a CMOS sensor. A 3D refractive index (RI) tomogram was then 
reconstructed from the series of off-axis holograms using the TomoStudioTM software (Tomocube 
Inc.) (Figure 1C). Further details of the algorithms used and principles of ODT can be found here 
(35).  
The 3D RI Tomograms of individual platelets were visualized and segmented to measure three-
dimensional morphological parameters, mean RI and dry mass within the TomoStudioTM software 
(Figure 1 D, E and Suppl video 1 A&B). 
 
Platelets from myeloid malignancies show changes in platelet morphologies and intracellular 
components  
Aberrant hemostasis and thrombosis is one of the most common causes of morbidity and mortality 
in JAK2V617F-positive MPN patients. Although some differences have been identified in platelet 
protein expression levels that would lead to a prothrombotic phenotype, the actual structure or 
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morphology of these platelets has yet not been visualized. In order to study the differences in these 
platelets from WT vs VF mice,  we used a previously characterized murine model system for 
JAK2V617F+ mice (20). Maximum RI projection images of unfixed platelets, freshly isolated from 
WT and VF mice indicated no visible change in the morphology (Figure 2A). However, 
quantitative analysis of the RI projection data indicated that had higher intensity compared to WT 
platelets (Figure 2B; P<0.001), suggesting differences in composition between platelets from these 
two strains. There were no significant differences between WT and VF platelets in surface area or 
volume, but VF platelets had a significant increase in sphericity (unpaired two-tailed t-test, P = 
0.1921, P = 0.5062 and P = 0.0063, respectively; Figure 2C). Thus, platelets in VF mice are altered 
in shape but not size.  
We next  created 3D iso-surface rendered images of the platelets based on a range of RIs, to provide 
data about cytosolic differences between cells (18, 19). The 3D iso-surface rendered images of the 
platelets from WT and JAK2V617F mice show a clear difference in the organization of RI materials 
within the platelets (Figure 2D). corresponding with the RI values (Figure 2E; unpaired two-tailed 
t-test, P = <0.0001) and a significant increase in the dry mass (unpaired two-tailed t-test, P = 
<0.0001).  
Bioactive molecules, such as those stored in alpha granules (containing membrane associated 
proteins - integrins, P-selectin, and soluble factors - vWF, factor V to name a few (36, 37)) and 
dense granules (mainly contain calcium, serotonin, histamines etc. (37)), are key components 
within the platelets that make them active and respond to specific agonists (10). In order to identify 
these granules and map the RI, we labelled the granules using membrane permeable dyes (38) and 
fixed the platelets with 4% PFA for 10 minutes. The PFA fixation at 10 minutes does not affect the 
size, shape, RI and dry mass of the platelets but leaving them from longer than 10 minutes 
significantly alters these parameters (Figure S1A-E). Unfortunately, although we could detect alpha 
and dense granules within the platelets, we were unable to measure the exact RI for the granules 
(Figure S2B and C).  
 
L. donovani infected mice have altered platelet morphologies and intracellular features 
To determine whether similar changes occurred in another pathological setting characterized by 
alterations in platelet numbers, we examined platelets from mice with experimental visceral 
leishmaniasis (27,28).  
Visible changes in the morphology of the platelets was observed in maximum RI projection images 
of the platelets freshly isolated from naïve and L. donovani-infected WT C57BL/6 mice (Figure 
3A). In contrast to VF mice (Figure 2), platelets from L.donovani-infected mice  have a much lower 
mean intensity (unpaired two-tailed t-test, P = 0.0038; Figure 3B). Platelets from infected mice had 
increased surface area and volume but reduced sphericity (unpaired two-tailed t-test all P = 
<0.0001; Figure 3C) Thus, platelets from infected mice had an increase in size as well as an altered 
intracellular environment and a suggestion, based on sphericity, of activation.   
Similar to the VF model, we also studied changes in the cytosolic parameters. Platelets from naïve 
and L.donovani-infected mice  also showed a visible difference in the RI (Figure 3D), with a 
significant reduction in higher RI based structures (unpaired two-tailed t-test, P = <0.0001; Figure 
3E). Unlike VF platelets, platelets from L. donovani-infected mice had an increase in dry mass 
(unpaired two-tailed t-test, P = <0.0001; Figure 3E). 
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 Discussion:  
Imaging based techniques are rising in popularity with the advancement of super-resolution 
imaging and the amount of quantitative information concerning the functioning of the cells that can 
be derived from such experiments. The field of platelet biology has taken advantage of these tools 
and a vast array of new and exciting information relating to the changes in the internal structure 
and function of platelets or platelet proteins during activation processes or disorders has recently 
been produced (12±14, 39, 40). With fluorescence based imaging, the protein of interest often 
requires the samples to have a fluorescent tag ± either genetically modified or by immuno-
labelling, to provide the contrast required for visualization.,. In our study, we use 3D 
holotomography, a refractive index-based imaging technique, that requires no labelling or post-
isolation processing, enabling us to study alterations in the cell morphology and changes in 
biophysical parameter of unaltered cells or platelets in health and disease.  
Obtaining enough platelets from mice to perform standard in vitro functional assays, such as lumi-
aggregometry or western blotting, has always been significant restraint for platelet studies. As a 
result, researchers are often limited to a single assay for each mouse.  However, the assays outlined 
here can be performed with a minimum volume of 10- 20 µl/chamber, allowing sampling of 100-
200 platelets at single cell level, sufficient to generate quantitative information relating to platelet 
morphology and refractive index/ dry mass. Therefore, this imaging technique can serve as a 
valuable additional or complementary technique to other in vitro platelet function assays. 
Here, we used this technique to study the morphological changes and alterations in the cellular 
composition of platelets directly isolated from two murine disease models. We isolated and imaged 
platelets from mice with either somatic mutations in JAK2, JAK2V617F, that cause 
myeloproliferative neoplasms or platelets from mice with experimental visceral leishmaniasis 
following infection with L. donovani. Both of these models have characteristic alterations in their 
platelets, leading to either thrombocytosis or thrombocytopenia with chronic inflammation giving 
rise to these fatal thrombotic or bleeding disorders (24, 26, 27, 41).  
Under normal physiological conditions, the vascular endothelium continuously suppresses platelet 
activation via expression of ectonucleotidases, thrombomodulin, or by releasing prostaglandin I2 
and nitric oxide. This is usually altered when there is an inflammatory environment or vascular 
injury that contributes to a prothrombotic phenotype, as seen in bleeding disorders (8). We have 
previously shown, using an alternative murine JAK2V617F-positive MPN model, that expression 
of the mutated protein in platelets did not have a significant effect on aggregation in vitro, and 
aberrant hemostasis was largely due to extreme thrombocytosis-LQGXFHGDFTXLUHGYRQ:LOOHEUDQG¶V
disease and an inflamed endothelial environment (24).  An inflamed endothelium is common in 
MPNs due to a chronic inflammatory environment and often leads to atherosclerosis and secondary 
cancers (26, 27). This inflammatory environment is characterized by increases in circulating 
thrombomodulin, selectins and von Willebrand factor. This is turn activates the endothelial cells 
lining the blood vessels, leukocytes and platelets (27). Thus the platelets have a significant role to 
play in the MPN bleeding complications, often with progression to secondary complications (24, 
26). In our study, platelets isolated from VF mice do not have a characteristic change in 
morphology, but do show an increase in the mean RI and dry mass (Figure 2) indicating 
intracellular changes within the platelets, which may largely be due to platelets being primed by 
the inflammatory environment for further activation and function. 
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The larger the size of the platelets, the greater is reactivity and prothrombotic ability (1, 42). 
Platelets from L. donovani infected C57BL/6 mice were found to be much larger in size and less 
spherical compared to the naïve platelets (Figure 3), presenting a much more morphologically 
activated state, accompanied by changes in the intracellular content. The larger platelets were also 
seen in H&E staining of blood smears from  infected mice ((29) and Rani G et al, unpublished). 
The mechanism(s) underlying these changes in platelets during infection remain to be determined. 
The inflammatory response to  L. major infection has previously been associated with platelet 
activation, release of platelet derived growth factor (PDGF) and amplification of monocyte 
recruitment via CCL-2 (41). Platelet activation is also known to alter sialylation of surface 
glycoproteins allowing recruitment to the inflamed liver and clearance by hepatocytes via Ashwell 
Morrell Receptor (29) (and Rani G et al, unpublished). Furthermore, an increase in the number of 
IgG-bound platelets in L. donovani infected mice likely underpins enhanced clearance of activated 
platelets, leading to severe thrombocytopenia in these models. The presence of larger platelets, as 
seen in our results, could also be due to newly formed platelets owing to increased turnover and 
changes in platelet biogenesis (Rani et al unpublished and (42).  
In both models studied, we noticed a different platelet RI for the WT and naïve mice and a non-
linear relationship of RI and dry mass between naïve and L. donovani infected platelets (Figure 2 
& 3). We currently do not know the effect of the different platelet isolation methods and buffers 
(see methods) have on the RI of the platelets. We speculate this to be one of the reasons resulting 
in the RI difference. Day to GD\FDOLEUDWLRQRIWKHV\VWHPEDVHGRQWKH³EXIIHUEDFNJURXQG´LVGRQH
prior to imaging which could also cause these minor alterations in the resulting RI between the two 
models.  
Based on ODT literature, RI and dry mass are linearly proportional (18, 19, 43). In the L. donovani 
infection model, this does not seem to be the case.  The naïve platelets, in the infection model, show 
a broad distribution of RI data sets ± some with higher RI and others lower. The corresponding dry 
mass shows a tighter distribution of the data set. This difference is noted in both models, with the 
WT mice having a tighter RI range and a broader dry mass in contrast to the naïve platelets. But 
strangely, this occurs only in the WT and naïve platelets, while the VF and L. donovani infected 
platelets do not show this pattern. Human platelets isolated from different donors have been shown 
to have some variation in their morphological and cytosolic parameters and also have altered 
activation patterns when stimulated (19). Therefore, the differences in our results may be an 
inherent property of the normal, uninfected platelets that may have gone unnoticed with other 
platelet assays. Thus, from these two differences highlighted in our results, we can only compare 
and contrast RI data from within one experimental data. 
Both mouse models used in our study share several hematological pathologies such as 
splenomegaly, largely associated with thrombocytopenia in leishmaniasis, and an inflammatory 
environment (26, 28, 44). This inflammatory environment causes an influx of immune cell 
responses, where platelets can act as mediators for generating these responses (11, 45). The role of 
platelets in innate immunity is largely due to their capacity to internalize viruses and bacteria, 
release of bioactive molecules stored in their granules and interaction with other cells i.e. leucocytes 
to combat a potential threat (46, 47).  Overall, the complex nature of platelet function as either pro- 
or anti- inflammatory, or the platelets having a beneficial or detrimental effect is entirely dependent 
on the cause of the inflammation and the pathophysiology of the disease as described in the review 
by Gros et al (11).  Here, using our label-free method of RI imaging, we were able to highlight that 
platelets isolated from our hematological and inflammatory disease models appear different in 
structure and size and cytosolic concentrations, compared to WT controls. Although there are some 
limitations in using the fluorescence-based imaging with this platform, there is more RI based 
information and real-time cell dynamics that can be tracked over time (19), allowing this method 
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to be used for studying the effect of different drugs on the activation states of platelets.  The 
technique also highlights the amount of valuable information that can be derived from only a 
fraction of the platelets isolated from mice, which will aid in complementing other functional 
assays of platelet activation.  
 
 
 
Figures: 
 
 
Figure 1. Label-free 3D ODT imaging of platelets.  A) Simplified schematic of a holotomographic 
microscope based on Mach-=HKQGHU LQWHUIHURPHWULF PLFURVFRS\ Ȝ-532nm, laser light source; 
DMD, digital micromirror device; L1-L3, lenses; CL, condenser lens 60x NA 1.2; Obj, objective 
lens 60x NA 1.2; M, mirror; BS1-2, beam splitter; Pol, polarizer; FL LED, fluorescence light 
source. B) Image acquisition/scanning of the sample based on sequential imaging at multiple angles 
to yield a total of 49 holograms. C) Representative cross-sectional 3D RI tomogram image of a 
platelet. Color bar represents refractive index.  D) Example of 3D surface rendering of the platelet 
sample used to measure morphological parameters. (See also Supp video 1A). E) Representative 
RI based rendering, where the pseudo coloring represents different bands of refractive index to 
highlight intracellular features of the platelet. (See also Supp video 1B)   
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 Figure 2: Morphological and biochemical differences in platelets from WT and JAK2V617F+ (VF) 
from murine blood. A) Max RI projections of the 3D phase images of platelets from WT and VF 
mice. B) The mean intensity values from the RI projections between WT and VF platelets (unpaired 
two-tailed t-test, P = < 0.0001, n = 80 platelets) C) Morphological changes of platelets from WT 
and VF mice in surface area platelets (unpaired two-tailed t-test, P = 0.1921)  , volume (unpaired 
two-tailed t-test, P = 0.5062) and sphericity (unpaired two-tailed t-test, P = 0.0063 n = 102 platelets, 
median represented by black line in the violin plot. Scale bar 2 µm. D) 3D rendered isosurface 
image of platelets from WT and VF mice based on RI. E) Changes in mean RI (unpaired two-tailed 
t-test, P = <0.0001) and dry mass (unpaired two-tailed t-test, P = <0.0001) of the platelets. Scale 
bar 1 µm, RI scales; Pink: 1.3426 ± 1.3483, blue: 1.3484 ± 1.3519, green: 1.3520 ± 1.3565, red: 
1.3566 ± 1.3628. 
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Figure 3: Morphological and biochemical differences in platelets from naïve and Leishmania 
infected mice. A, B) Max RI projections of the 3D phase images of platelets from Naïve and L. 
donovani infected mice n = 23 platelets. C) Morphological changes seen in platelets in surface area, 
volume and sphericity. n = 62 platelets, 10 platelets from each WT mice in study (6 mice) and n= 
172 platelets from 17 L. donovani infected mice, median represented by black line in the violin 
plot. Scale bar 2 µm. D) 3D rendered isosurface image of platelets from naïve and L. donovani 
infected mice based on RI. Scale bar 1 ȝm. E) Changes in mean RI (unpaired two-tailed t-test, P = 
<0.0001), and dry mass (unpaired two-tailed t-test, P = <0.0001) of the platelets. RI index scales; 
Pink: 1.3406-1.3525, blue: 1.3525 ± 1.3621, green: 1.3622 ± 1.3735, red: 1.3736 ± 1.3822. 
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Supplementary information: 
 
 
Supplementary Figure 1: 4% PFA fixation on platelets at varying time scales. A-E) Morphological 
and biochemical parameters affected by PFA fixation A) Surface area ( P = 0.3263, 0.0010, 
0.0083), B) Volume (P = 0.4913, <0.0001, 0.0004), C) Sphericity (P = 0.1521, 0.0027, 0.0103), D) 
RI (P = 0.4214, 0.9495, 0.6858) and E) Dry mass (P = 0.7976, 0.0005, 0.0001). Paired two tailed 
t-test was performed for all, n= 30. RI: Pink: 1.3444 ± 1.3525, blue: 1.3526 ± 1.3621, brown: 1.3622 
± 1.3719, red: 1.3720 - 1.3775. 
Supplementary videos: 1A and 1B  
See attached videos 
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